Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 5Head & Neck 4Thoracic 2Genitourinary 2Breast 2Other solid neoplasm 1

Conditions

Nasopharyngeal Carcinoma 2Squamous Cell Carcinoma of Head and Neck 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 30pembrolizumab 24Magnetic Resonance Spectroscopy 24Specimen Handling 20Cetuximab 18Nivolumab 15Carboplatin 14Platinum 121,2-diaminocyclohexaneplatinum II citrate 12Radiotherapy, Intensity-Modulated 11Radiotherapy 10Radiation 9Paclitaxel 9Docetaxel 8Biopsy 8Immunoglobulin G 7Disulfides 7Surveys and Questionnaires 6Ipilimumab 6atezolizumab 5Fluorouracil 5toripalimab 4dostarlimab 4cemiplimab 4cabozantinib 4Taxes 4Gemcitabine 4CTLA-4 Antigen 4Bevacizumab 4(225)Ac-DOTA-c(RGDyK) 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
toripalimab × Head & Neck × 30 days × Clear all
NCT07625423 2026-06-04

EDS01 HN

West China Hospital

Phase 1 Recruiting
9 enrolled
Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms

NCT07325539 2026-05-22

LIGHT

Sun Yat-sen University

Phase 2 Recruiting
55 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT06378177 2026-05-19

A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

Lyvgen Biopharma Holdings Limited

Phase 2 Active not recruiting
64 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06277050 2026-05-15

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Jiangxi Provincial Cancer Hospital

Phase 3 Recruiting
264 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡